NewsPeople

Nativ Segev, Founder, MGC Pharmaceuticals joins HempStreet Advisory Board

HempStreet is set to take the global stage by disrupting the global medicinal cannabis industry starting with transdermal delivery innovation

HempStreet announced that Nativ Segev, the founder of MGC Pharmaceuticals, has joined their advisory board. With this association, HempStreet intends to grow steadily in one of the world’s fastest-growing medicinal cannabis spaces and create a Made in India brand for the world by setting new industry benchmarks on the global stage. HempStreet is committed to facilitating high decibel awareness and clinical activities supporting the company’s product lines en route to market leadership.

Nativ Segev is an internationally acclaimed name in the global medicinal cannabis space. A self-starting, highly connected entrepreneur with experience in creating new businesses and finding their niche. He also played a role in medical cannabis regulation in Israel and the Czech Republic, alongside developing new medical treatments and spearheading the discovery of new strains. He founded MGC Pharmaceuticals to expand into the huge worldwide market for cannabinoids in the pharmaceutical industry. 

Under his leadership, MGC Pharmaceuticals has taken the global medical cannabis industry by storm with a growing patient base in Australia, the UK, Brazil, and Ireland. The company has a global distribution footprint via an extensive network of commercial partners meaning that it is poised to supply the global market. Its research and development agenda, coupled with the company’s robust clinical platform sets it at the forefront of this significant emerging segment of the global pharmaceutical market.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close